Related Experiment Video
Updated: Nov 1, 2025

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Pneumococcal Bacteremia and Cryptococcal Meningitis Dual Infection in a Patient With Multiple Myeloma
Abdul Raheem1, Balram Rathish2, Deepak Charles3
1Internal Medicine, Aster Medcity, Kochi, IND.
Multiple myeloma patients face high infection risks due to disease and chemotherapy. A rare dual infection of pneumococcal bacteremia and cryptococcal meningitis in a myeloma patient had a favorable outcome, emphasizing adult vaccination importance.
Area of Science:
- Infectious Diseases
- Hematology
- Immunology
Background:
- Multiple myeloma (MM) patients exhibit increased susceptibility to infections, a major cause of morbidity and mortality.
- Impaired immune function in MM arises from the disease itself and cytotoxic chemotherapy regimens.
- Prophylactic measures, including vaccination, are crucial for managing infectious complications in immunocompromised patients.
Observation:
- A rare case of concurrent pneumococcal bacteremia and cryptococcal meningitis is presented in a patient with multiple myeloma.
- The patient presented with symptoms indicative of a severe dual bloodstream and central nervous system infection.
- Despite the severity, the patient received appropriate antimicrobial therapy and supportive care.
Findings:
- Successful treatment and favorable clinical outcome were achieved for the dual infection in the multiple myeloma patient.
- Prompt diagnosis and targeted antimicrobial therapy were key to managing the complex infectious scenario.
- The case underscores the potential for severe, yet treatable, opportunistic infections in MM patients.
Implications:
- This case highlights the critical need for vigilance regarding opportunistic infections in multiple myeloma patients.
- It emphasizes the significant benefit of adult vaccination strategies in immunocompromised individuals, particularly those with hematologic malignancies.
- Early recognition and management of dual infections can lead to positive patient outcomes, improving quality of life and survival rates.
More Related Videos
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pneumonia III: Complications and Assessment
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: